Clinical Trials Directory

Trials / Completed

CompletedNCT07297719

Evaluation of Glistening, Visual Outcomes and General Safety 24 Months Post-IOL Implantation

A Non-interventional, Single-visit Study Focusing on the Evaluation of Glistening as Well as General Safety and Visual Outcomes With at Least 24 Months Follow-up in Patients Implanted With CT LUCIA 621P Intraocular Lenses

Status
Completed
Phase
Study type
Observational
Enrollment
33 (actual)
Sponsor
Carl Zeiss Meditec AG · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Main evaluation of glistening at least 24 Months post-IOL implantation

Detailed description

Evaluation of glistening, visual outcomes and general safety after at least 24 Months post-IOL implantation

Conditions

Timeline

Start date
2025-12-25
Primary completion
2025-12-31
Completion
2025-12-31
First posted
2025-12-22
Last updated
2026-01-16

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT07297719. Inclusion in this directory is not an endorsement.

Evaluation of Glistening, Visual Outcomes and General Safety 24 Months Post-IOL Implantation (NCT07297719) · Clinical Trials Directory